Evidence map›Paper›PMID 26676574›Full record

ArticleMolecular neurobiology2016

Increased Wnt Signaling and Reduced Viability in a Neuronal Model of Progranulin-Deficient Frontotemporal Lobar Degeneration.

Ana de la Encarnación, Carolina Alquézar, Ángeles Martín-Requero

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Effects of Wnt5a overexpression in spinal cord injury.Journal of cellular and molecular medicine · 2021
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ana de la EncarnaciónDepartment of Cellular and Molecular Medicine, Centro de Investigaciones Biológicas (CSIC) Madrid, Madrid, Spain.
Carolina AlquézarDepartment of Cellular and Molecular Medicine, Centro de Investigaciones Biológicas (CSIC) Madrid, Madrid, Spain.
Ángeles Martín-RequeroDepartment of Cellular and Molecular Medicine, Centro de Investigaciones Biológicas (CSIC) Madrid, Madrid, Spain. amrequero@cib.csic.es.
Centro de Investigaciones Biológicas Margarita Salas · ESInstituto de Investigación de Enfermedades Raras · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Progranulin (PGRN) deficiency is considered the major cause of frontotemporal lobar degeneration with TDP-43 protein inclusions (FTLD-TDP). Recent work unveiled a relationship between Wnt signaling and PGRN in cellular models of FTLD and cells of patients carrying loss-of-function GRN mutations. This study was undertaken to explore the relationship between PGRN deficit and Wnt signaling in the regulation of survival of GRN knockdown neuroblastoma SH-SY5Y cells (GRN KD). We report here that both canonical and noncanonical Wnt signaling cascades are overactivated in GRN KD cells. We detected increased expression levels of Wnt1 and Wnt5a ligands of the Frizzled receptors, as well as evidence for increased signaling of the Wnt/β-catenin and Wnt/Ca

Indexed as

Models, BiologicalWnt Signaling PathwayAnimalsBromodeoxyuridineCell Line, TumorCell ProliferationCell SurvivalCulture Media, ConditionedDNAFrontotemporal Lobar DegenerationGene Knockdown TechniquesHumansIntercellular Signaling Peptides and ProteinsMiceNeuronsProgranulinsBromodeoxyuridineCulture Media, ConditionedDNAGRN protein, humanIntercellular Signaling Peptides and ProteinsProgranulinsCell cycleCell survivalProgranulin FTLD-TDPWnt1Wnt5a

Identifiers

PMID26676574
OpenAlexW2257452754

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.